Found: 12
Select item for more details and to access through your institution.
The impact of dasatinib on pregnancy outcomes.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 12, p. 1111, doi. 10.1002/ajh.24186
- By:
- Publication type:
- Article
Risks and challenges of CML management during pregnancy: Looking for a balanced decision.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 4, p. 378, doi. 10.1111/ejh.13215
- By:
- Publication type:
- Article
Clinical Outcomes in Patients With COVID-19 and Hematologic Disease.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 8, p. 589, doi. 10.1016/j.clml.2023.04.002
- By:
- Publication type:
- Article
Withdrawal Syndrome After Tyrosine Kinase Inhibitor Discontinuation in Patients With Chronic Myeloid Leukemia in the Russian Prospective Study RU-SKI.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Analysis of Mortality of the Multicenter Eutos Eln Population-Based Study (EUTOS-PBS) in Russian Patients with Chronic Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S298, doi. 10.1016/j.clml.2019.07.252
- By:
- Publication type:
- Article
Withdrawal Syndrome After Tyrosine Kinase Inhibitors Discontinuation in Patients with Chronic Myeloid Leukemia in Russian Prospective Study (RU-SKI).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S291, doi. 10.1016/j.clml.2019.07.237
- By:
- Publication type:
- Article
Treatment of Patients with Chronic Myeloid Leukemia During Pregnancy According to Scheme Considering the Leukemic Burden and Term of Pregnancy (the LRT Scheme).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S227, doi. 10.1016/j.clml.2018.07.102
- By:
- Publication type:
- Article
The ability of multipotent mesenchymal stromal cells from the bone marrow of patients with leukemia to maintain normal hematopoietic progenitor cells.
- Published in:
- European Journal of Haematology, 2016, v. 97, n. 3, p. 245, doi. 10.1111/ejh.12713
- By:
- Publication type:
- Article
Exome, transcriptome and miRNA analysis don't reveal any molecular markers of TKI efficacy in primary CML patients.
- Published in:
- BMC Medical Genomics, 2019, v. 12, n. 2, p. N.PAG, doi. 10.1186/s12920-019-0481-z
- By:
- Publication type:
- Article
Copy number variation analysis in cytochromes and glutathione S-transferases may predict efficacy of tyrosine kinase inhibitors in chronic myeloid leukemia.
- Published in:
- PLoS ONE, 2017, v. 12, n. 9, p. 1, doi. 10.1371/journal.pone.0182901
- By:
- Publication type:
- Article
Tyrosine kinase inhibitors and pregnancy in chronic myeloid leukemia: opinion, evidence, and recommendations.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720966120
- By:
- Publication type:
- Article
Frequent variations in cancer-related genes may play prognostic role in treatment of patients with chronic myeloid leukemia.
- Published in:
- BMC Genetics, 2016, v. 17, p. 35, doi. 10.1186/s12863-015-0308-7
- By:
- Publication type:
- Article